Jul. 2021

In July 2021, Suzhou Fuent Pharmaceutical Co., Ltd. (Qurgen’s China subsidiary) was established in the Life & Health Town Industrial Park, Suzhou. The company invested 5 million RMB to build a 641-square-meter non-GMP laboratory as the company’s R&D facility of transcription factor drug development for treatment of major human diseases including cancer, heart failure and anti-aging etc.